The GlycoCalyx Research Institute at LM2026: who we are, ReVasca™ and the research
Welcome to LM2026 · Orlando · November 8–11, 2026
The GlycoCalyx Research Institute
Measure. Restore. Verify.
Thank you for scanning our poster, “Integrating Microvascular Glycocalyx Assessment into Lifestyle Medicine.” We are the scientists and clinicians behind it. Here is who we are, what we make, and the research it all rests on.
GlycoCheck code
GlycoCalyx code
Two codes on the poster, one beside each logo. You are on the highlighted one; tap the other to switch.
Who we are
Twenty years of glycocalyx science, made practical
The GlycoCalyx Research Institute was founded in 2012 by vascular scientist Dr Hans Vink and Robert Long to turn glycocalyx research into tools clinicians can use. We teach, we keep a library of the peer-reviewed research, and we develop nutraceuticals whose effect can be measured. Our sister company GlycoCheck brings Dr Vink’s measurement system to US clinics; both sit within Genesis Health Sciences.
Hans Vink, PhD
A pioneer of endothelial glycocalyx research and the inventor of the GlycoCheck™ measurement. Co-author of the poster.
Robert (Bob) Long
Started down this road after his own health scare in 2009, and has spent fifteen years turning the science into clinical practice. Co-author of the poster.
What we do
Measure
GlycoCheck™ images the glycocalyx under the tongue and scores microvascular health in under five minutes.
Restore
ReVasca™ and the lifestyle-medicine pillars: nutrition, activity, sleep, stress and risk-factor reduction.*
Verify
Measure again. Results you can see and show a patient, rather than claims to take on trust.
Why the glycocalyx
Most of your circulation is too small to see
Heart and arteries get the attention. The exchange of oxygen and nutrients happens in the microvessels, and every one of them is lined with the glycocalyx.
The heart and large vessels: the plumbing that carries blood toward the tissue.
The microvessels, lined with the endothelial glycocalyx, where delivery to every cell actually happens. As the layer thins, delivery fails first, often long before a standard test finds anything.
- 60,000miles of vessels lined by the glycocalyx
- 10,000square feet: the body’s largest surface
- 40+the age at which capillary loss accelerates
- 20+years of glycocalyx research behind our work
The paper on our poster
Why we measure before we restore
Six years, 600 people, one measurement. A damaged glycocalyx predicted heart attack, stroke and cardiovascular death beyond every conventional risk factor.
Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6-Year Follow-up Study
Ignatios Ikonomidis et al. · Journal of Cardiovascular Translational Research, published online October 28, 2021
Major adverse cardiovascular events: cardiovascular death, myocardial infarction and stroke; 57 occurred during follow-up. Net reclassification improvement 39.7%; C-statistic 0.653 to 0.693 (p < 0.01). The glycocalyx was measured as the perfused boundary region (PBR) in sublingual vessels 5–25 µm across. ClinicalTrials.gov NCT04646252. The journal article is subscription access; our page carries the full abstract and a link to it.
Restore
ReVasca™: endothelial glycocalyx support*
Formulated by the scientists who pioneered glycocalyx measurement, to supply the building blocks of the glycocalyx and support healthy nitric oxide production and microvascular circulation.* Capsules or a grape drink mix.
- L-Citrulline
- Fucoidan (85%)
- ViNitrox® apple & grape
- Vascaman™ aloe vera
- Hyaluronic acid
- Catalase
- Superoxide dismutase
Sport
Informed Sport certified. Every batch of capsules and drink mix is screened for substances banned in sport. View the certificate
Measured, not claimed
MicroVascular Health Score™ before and after 12 weeks taking ReVasca™. Individual results may vary.
Order ReVasca™
The rest of the family
Ask our research library
Ask a question in plain English. The answer is written from the peer-reviewed papers in our library, and every claim links to the paper it came from.
Questions & answers
Questions we are often asked
How is ReVasca™ taken?
Capsules: four a day, ideally two in the morning and two in the afternoon or evening, with or without food. Drink mix: one scoop a day. Each single is a 30-day supply. Full Supplement Facts and directions.
What is in ReVasca™?
Seven actives in one blend: L-citrulline, fucoidan, ViNitrox® apple and grape polyphenols, Vascaman™ organic inner-leaf aloe vera, hyaluronic acid, catalase and superoxide dismutase. It contains soy (from the SOD) and is non-GMO, gluten-free and vegan.
Is ReVasca™ tested for banned substances?
Yes. Both the capsules and the drink mix are Informed Sport certified, so every batch is screened for substances banned in sport before release.
How do I know whether it is working?
Measure it. A GlycoCheck™ reading before you start and again after about three months shows the change in your own vessels rather than leaving you to guess. Find a test location.
I take medication. Can I take ReVasca™?
Please check with your healthcare professional first, as the label advises for anyone who is pregnant, nursing, taking medication or under medical supervision.
Can my practice offer ReVasca™ to patients?
Yes. Get in touch about practitioner and affiliate accounts.
Before you walk on
Keep in touch after Orlando
Conference days are long. Save our details or send this page to a colleague who missed the poster.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
GlycoCheck™ is a Class I medical device used to assess microvascular health. Poster: “Integrating Microvascular Glycocalyx Assessment into Lifestyle Medicine,” presented at Lifestyle Medicine 2026, American College of Lifestyle Medicine, Orlando, November 8–11, 2026.
GlycoCalyx Research Institute · 2701 North Thanksgiving Way, Suite 100, Lehi, UT 84043 · 833-42-GLYCO (833-424-5926) · support@glycocalyx.com